Body Roundness Index Predicted Depression Symptoms in Dementia

TL;DR: A 2026 Journal of Health Psychology study found body roundness index (BRI), a waist-and-height shape measure, identified dementia patients with higher odds of depressive symptoms better than body mass index did.

Source: Journal of Health Psychology (2026) | Fernandes et al.

Depression in dementia hides in plain sight. It can appear as withdrawal, apathy, slowed conversation, sleep disruption, appetite change — symptoms that are easy to misread as cognitive decline progressing rather than mood declining alongside it.

Clinicians know this, and screening tools exist, but in a memory clinic with limited time, having one extra reason to ask directly about mood can help.

This study suggests that one extra reason might come from a tape measure. Body roundness index — a waist-and-height-based measure of central adiposity — flagged a depression-risk signal in dementia patients that BMI was simply blind to.

BMI Performed Poorly for Depression Risk in Older Adults With Dementia

BMI is convenient because every clinic already calculates it, but aging makes it a blunt instrument.

Older adults can lose muscle and bone while accumulating abdominal fat. Their weight relative to height tells you less and less about what is actually happening in the body — particularly the visceral fat that drives inflammation and metabolic stress.

Body roundness index uses height and waist circumference instead. The waist measurement is relevant because abdominal fat is metabolically active in ways that body weight alone does not capture.

For dementia patients — who are already vulnerable to inflammatory, vascular, and endocrine stress — that distinction is not cosmetic. It is biological.

BRI Depression Link Appeared Only in Dementia

The cohort included 601 older adults from a memory clinic, 239 of whom had a dementia diagnosis. Across the full sample, no body-fat measure predicted depressive symptoms. So the headline here is not a generic obesity-depression finding.

The pattern emerged only when the analysis was restricted to the dementia subgroup. In those 239 patients, about 36% met the GDS-15 cutoff for depressive symptoms (a score of 5 or higher on the 15-item Geriatric Depression Scale), and BRI tracked that depression-risk pattern cleanly.

The highest BRI quartile showed more than 3-fold higher odds of depression than the lowest. BMI and waist circumference, examined the same way in the same people, did not.

This is the kind of result that should change how the obesity-depression literature is read in older populations. The relationship is not necessarily uniform. It may live inside specific clinical groups where the biology is already strained.

Central Adiposity, Inflammation, and a Vulnerable Brain

Why would BRI catch an association that BMI cannot? The likely answer is what the two indexes are actually measuring. BRI is more sensitive to central adiposity — the visceral fat distribution most strongly tied to low-grade inflammation, insulin resistance, vascular dysfunction, and endocrine stress.

Each of those pathways already touches dementia care. A patient who is metabolically stressed in the abdomen is also more likely to be inflamed, more likely to have vascular fragility, and more likely to carry the kind of background biology that interacts with mood circuitry. A measurement that captures shape rather than weight may pick up a body-brain risk profile that weight-divided-by-height-squared simply averages over.

This study did not measure inflammatory markers, hormones, or cardiometabolic biology directly. The mechanism remains a hypothesis. But it is a hypothesis with biological plausibility — and it explains why BRI’s discriminative power emerged in the dementia subgroup specifically.

Cross-Sectional BRI Data Cannot Prove Depression Causality

The design was cross-sectional, so the threefold odds figure cannot separate central adiposity, inflammation, vascular strain, sleep disruption, activity changes, dementia severity, and depression timing. Three possibilities remain on the table:

• Central adiposity is one driver — through inflammation, vascular strain, or hormonal stress.
• Depression alters body composition — through reduced activity, disrupted sleep, or appetite changes that shift fat distribution.
• A third factor drives both — frailty, medication burden, dementia severity, or cardiometabolic disease.

The clinical reading should stay narrow: BRI may help flag dementia patients who need closer mood screening, not diagnose depression by body shape. the finding is a clue, not a verdict.

Body Roundness Index Is Cheap Enough for Dementia Clinics to Use

The most clinically attractive thing about BRI is not its math. It is that the measurements already exist in every memory-clinic intake — height and waist circumference.

No scanner, no blood test, no new instrument. In dementia care, where appointment time is short and depression hides inside cognitive symptoms, a low-friction risk flag has real value if it reliably points clinicians toward the patients who need a more thorough mood assessment.

The result also fits a broader pattern in neurodegenerative care: the brain is not isolated from the body. Vascular risk, metabolic stress, inflammation, nutrition, sleep, and mood feed into the same clinical trajectory. Body roundness index is less about appearance and more about metabolic stress around a vulnerable brain.

BRI Depression Studies Need Longitudinal Dementia Follow-Up

The next test is longitudinal. Does higher BRI predict new depressive symptoms in dementia?

Does it predict persistent symptoms? Does it predict poorer response to standard depression treatment? Does it add information beyond what clinicians already know from a patient’s frailty, diabetes status, cardiovascular history, or dementia severity?

If longitudinal data show that BRI predicts later depressive symptoms, it could become a practical screening variable. If not, this result remains a cross-sectional association that needs stronger follow-up before it changes dementia care.

For now, the most useful framing is the modest one. Dementia care is not only about memory. Mood, metabolism, and body composition are part of the same clinical picture — and a tape measure may help notice the part of that picture that is easiest to miss.